全文获取类型
收费全文 | 17309篇 |
免费 | 1093篇 |
国内免费 | 47篇 |
专业分类
耳鼻咽喉 | 213篇 |
儿科学 | 372篇 |
妇产科学 | 458篇 |
基础医学 | 2841篇 |
口腔科学 | 426篇 |
临床医学 | 1776篇 |
内科学 | 3140篇 |
皮肤病学 | 342篇 |
神经病学 | 1647篇 |
特种医学 | 877篇 |
外科学 | 2631篇 |
综合类 | 117篇 |
一般理论 | 2篇 |
预防医学 | 904篇 |
眼科学 | 569篇 |
药学 | 1196篇 |
中国医学 | 56篇 |
肿瘤学 | 882篇 |
出版年
2023年 | 63篇 |
2021年 | 245篇 |
2020年 | 155篇 |
2019年 | 294篇 |
2018年 | 336篇 |
2017年 | 284篇 |
2016年 | 345篇 |
2015年 | 363篇 |
2014年 | 499篇 |
2013年 | 723篇 |
2012年 | 988篇 |
2011年 | 983篇 |
2010年 | 664篇 |
2009年 | 624篇 |
2008年 | 972篇 |
2007年 | 1052篇 |
2006年 | 1062篇 |
2005年 | 1080篇 |
2004年 | 883篇 |
2003年 | 875篇 |
2002年 | 851篇 |
2001年 | 170篇 |
2000年 | 121篇 |
1999年 | 157篇 |
1998年 | 160篇 |
1997年 | 125篇 |
1996年 | 117篇 |
1995年 | 144篇 |
1994年 | 111篇 |
1993年 | 119篇 |
1992年 | 91篇 |
1991年 | 80篇 |
1990年 | 74篇 |
1988年 | 64篇 |
1985年 | 66篇 |
1984年 | 84篇 |
1983年 | 62篇 |
1982年 | 91篇 |
1981年 | 80篇 |
1933年 | 97篇 |
1932年 | 93篇 |
1931年 | 81篇 |
1930年 | 83篇 |
1929年 | 76篇 |
1928年 | 78篇 |
1927年 | 69篇 |
1926年 | 80篇 |
1924年 | 77篇 |
1923年 | 76篇 |
1922年 | 61篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Karl Johnson Katherine W. Saylor Isabella Guynn Karen Hicklin Jonathan S. Berg Kristen Hassmiller Lich 《Genetics in medicine》2022,24(2):262-288
PurposeUnderstanding the value of genetic screening and testing for monogenic disorders requires high-quality, methodologically robust economic evaluations. This systematic review sought to assess the methodological quality among such studies and examined opportunities for improvement.MethodsWe searched PubMed, Cochrane, Embase, and Web of Science for economic evaluations of genetic screening/testing (2013-2019). Methodological rigor and adherence to best practices were systematically assessed using the British Medical Journal checklist.ResultsAcross the 47 identified studies, there were substantial variations in modeling approaches, reporting detail, and sophistication. Models ranged from simple decision trees to individual-level microsimulations that compared between 2 and >20 alternative interventions. Many studies failed to report sufficient detail to enable replication or did not justify modeling assumptions, especially for costing methods and utility values. Meta-analyses, systematic reviews, or calibration were rarely used to derive parameter estimates. Nearly all studies conducted some sensitivity analysis, and more sophisticated studies implemented probabilistic sensitivity/uncertainty analysis, threshold analysis, and value of information analysis.ConclusionWe describe a heterogeneous body of work and present recommendations and exemplar studies across the methodological domains of (1) perspective, scope, and parameter selection; (2) use of uncertainty/sensitivity analyses; and (3) reporting transparency for improvement in the economic evaluation of genetic screening/testing. 相似文献
2.
Hajrunisa Cubro Karl A. Nath Sonja Suvakov Oscar Garcia-Valencia Santosh Parashuram Wendy M. White Tracey L. Weissgerber Meryl C. Nath Natasa M. Milic Fernando Sontag Livius V. d’Uscio Yi Zhu James L. Kirkland Tamar Tchkonia Mariam P. Alexander Reade A. Quinton Zvonimir S. Katusic Joseph P. Grande Vesna D. Garovic 《Kidney international》2021,99(3):646-656
3.
4.
5.
6.
7.
Robert Justo Cameron Ward Anthony Slater Julie McEniery Phil Sargent Alan Isles Tom R Karl Nelson Alphonso 《Journal of paediatrics and child health》2020,56(6):833-837
We describe a complex change process for the paediatric cardiac service in Queensland that involved transitioning the service out of an essentially adult hospital into one of two children's hospitals in Brisbane. This initial step was complex as the governance was changed from Queensland Health to Mater Health, an independent faith‐based organisation who became the new employer. Six years later, the service was again transitioned; this time to the newly constructed Queensland Children's Hospital, with a Hospital and Health Services Board as the employer under the aegis of Queensland Health. This was a complex journey. As with all change processes there was resistance to change on the part of some individuals. Five years on from the second major change, the service is settled, has an excellent workplace culture, has excellent clinical outcomes and has become research intensive. 相似文献
8.
9.